Cancer research is constantly evolving. Recent advances include the development of _personalized medicine_, which tailors treatment to the genetic makeup of the patient's tumor, and _CAR-T cell therapy_, a type of _immunotherapy_ that modifies the patient’s T cells to attack cancer cells more effectively. _Clinical trials_ are an essential aspect of this research, offering patients access to cutting-edge treatments.